U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07143513) titled 'Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients' on Aug. 20.
Brief Summary: The primary objective of this study is to characterize the safety profile of sotorasib.
Study Start Date: Aug. 30
Study Type: OBSERVATIONAL
Condition:
Non-Small Cell Lung Cancer
Intervention:
DRUG: Sotorasib
Participants will have received sotorasib orally daily until disease progression or unacceptable toxicity.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Amgen
Disclaimer: Curated by HT Syndication....